Position in SCYX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$172,948
+$52,994 QoQ
Shares Held
23,575
-0.6% QoQ
Ownership
0.237%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SCYX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Yakira Capital Management, Inc. holds $0 across 1 Drug Manufacturers - Specialty & Generic name.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | 550,011 | $0 |
All Filings in SCYX
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $172,948 | 188,602 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $119,954 | 189,802 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $146,147 | 189,802 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $128,116 | 189,802 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $180,691 | 189,802 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $229,660 | 189,802 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $282,804 | 189,802 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $365,270 | 182,635 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $295,374 | 200,935 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $448,085 | 200,935 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $335,889 | 147,320 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $252,012 | 85,428 | Shares | Sole | 2023-08-11 | |
| No filing history on record for this holder in this stock. | ||||||